BioScrip Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
Go back to BioScrip Reports Second Quarter 2015 Financial Results
August 11, 2015 7:15 AM EDT
SunTrust Robinson Humphrey downgraded BioScrip (NASDAQ: BIOS) from Buy to Neutral with a price target of $2.00 (from $5.00).
For an analyst ratings summary and ratings history on BioScrip click here. For more ratings news on BioScrip click here.
Shares of BioScrip closed at $2.08 yesterday.
...
More
August 10, 2015 7:06 AM EDT
BioScrip (NASDAQ: BIOS) reported Q2 EPS of ($3.60), which may not compare with the analyst estimate of ($0.08). Revenue for the quarter came in at $262.4 million versus the consensus estimate of $269.38 million.
Consolidated Adjusted EBITDA was a loss of $2.5 million, a $13.5 million decrease compared to Adjusted EBITDA of $11.0 million in the prior year period. The decrease was primarily due to a lower gross margin revenue mix shift as well as the increase of contractual and bad debt expense; and
BioScrip announced a multi-step plan to enhance shareholder value, improve financial flexibility and position... More
